| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Clovis Oncology, Inc. | Officer | Common Stock | 113,691 | $111,747 | $0.9829 | 02 Nov 2022 | Direct |
| CERO THERAPEUTICS HOLDINGS, INC. | Director | Stock Option (Right to Buy) | 690,900 | 07 Jan 2026 | Direct | ||
| Clovis Oncology, Inc. | Officer | Restricted Stock Units | 23,125 | 01 Nov 2022 | Direct | ||
| Atreca, Inc. | Director | Stock Option (right to buy) | 12,000 | 13 Jun 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| CERO | CERO THERAPEUTICS HOLDINGS, INC. | 07 Jan 2026 | 1 | $0 | 4 | Director | 09 Jan 2026, 16:30 |
| CERO | CERO THERAPEUTICS HOLDINGS, INC. | 30 May 2025 | 1 | $0 | 4 | Director | 02 Jun 2025, 17:06 |
| CERO | CERO THERAPEUTICS HOLDINGS, INC. | 04 Mar 2025 | 1 | $0 | 4 | Director | 06 Mar 2025, 16:16 |
| CERO | CERO THERAPEUTICS HOLDINGS, INC. | 24 Feb 2025 | 1 | $0 | 4 | Director | 26 Feb 2025, 18:06 |
| CERO | CERO THERAPEUTICS HOLDINGS, INC. | 02 Dec 2024 | 1 | $0 | 4 | Director | 04 Dec 2024, 21:12 |
| CERO | CERO THERAPEUTICS HOLDINGS, INC. | 25 Mar 2024 | 1 | $0 | 4 | Director | 27 Mar 2024, 21:29 |
| CERO | PHOENIX BIOTECH ACQUISITION CORP. | 14 Feb 2024 | 0 | $0 | 3 | Director | 16 Feb 2024, 19:29 |
| BCEL | Atreca, Inc. | 13 Jun 2023 | 1 | $0 | 4 | Director | 15 Jun 2023, 18:10 |
| CLVS | Clovis Oncology, Inc. | 01 Nov 2022 | 6 | -$4,188 | 4 | Officer | 03 Nov 2022, 16:15 |
| CLVS | Clovis Oncology, Inc. | 01 Sep 2022 | 3 | -$3,054 | 4 | Officer | 06 Sep 2022, 16:15 |
| CLVS | Clovis Oncology, Inc. | 01 Aug 2022 | 6 | -$6,326 | 4 | Officer | 03 Aug 2022, 16:15 |
| BCEL | Atreca, Inc. | 08 Jun 2022 | 1 | $0 | 4 | Director | 10 Jun 2022, 18:42 |
| CLVS | Clovis Oncology, Inc. | 01 Jun 2022 | 3 | -$1,703 | 4 | Officer | 03 Jun 2022, 16:15 |
| CLVS | Clovis Oncology, Inc. | 01 May 2022 | 6 | -$8,376 | 4 | Officer | 03 May 2022, 16:15 |
| CLVS | Clovis Oncology, Inc. | 01 Mar 2022 | 7 | -$20,423 | 4 | Officer | 03 Mar 2022, 15:15 |
| CLVS | Clovis Oncology, Inc. | 01 Feb 2022 | 6 | -$8,756 | 4 | Officer | 03 Feb 2022, 15:17 |
| CLVS | Clovis Oncology, Inc. | 01 Dec 2021 | 3 | -$1,038 | 4 | Officer | 03 Dec 2021, 15:16 |
| CLVS | Clovis Oncology, Inc. | 01 Nov 2021 | 6 | -$19,151 | 4 | Officer | 03 Nov 2021, 16:18 |
| CLVS | Clovis Oncology, Inc. | 01 Sep 2021 | 3 | -$1,697 | 4 | Officer | 03 Sep 2021, 16:15 |
| CLVS | Clovis Oncology, Inc. | 01 Aug 2021 | 6 | -$20,220 | 4 | Officer | 03 Aug 2021, 21:32 |
| BCEL | Atreca, Inc. | 09 Jun 2021 | 1 | $0 | 4 | Director | 11 Jun 2021, 16:31 |
| CLVS | Clovis Oncology, Inc. | 01 Jun 2021 | 3 | -$1,813 | 4 | Officer | 03 Jun 2021, 19:00 |